BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Epigenic Therapeutics Raises $32M for Breakthrough Epigenome Medicine Development

This round of financing will support the preclinical development and early clinical validation of two leading programs, discovery of future pipelines, expa...

August 30, 2023 | News

GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

Under the MOU, both parties agreed to cooperate for a successful supply of the vaccine. While Eubiologics, a developer and producer of Euvichol, takes char...

August 28, 2023 | News

BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research

The newly developed XDC bioconjugation platform offered by BOC Sciences introduces a range of advanced technologies and optimized protocols, revolutionizin...

August 25, 2023 | News

EU Commission Approves Pfizer's ABRYSVO™ for Infant and Elderly RSV Protection

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bival...

August 25, 2023 | News

PeptiGrowth & Orizuru Therapeutics Partner for Synthetic Peptide Growth Factor

OZTx, with the aim of social implementation of cell therapy products and innovative iPS cell-related technologies (platform innovation), is conducting rese...

August 25, 2023 | News

SK Bioscience and Vaxxas Partner for Needle-Free Typhoid Vaccine Patch

SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collaboration is set to revolutionize vaccine delivery by devel...

August 24, 2023 | News

Sanyou and Sinorda Partner for Innovative Drug Research

According to the cooperation agreement, leveraging Sanyou's world-leading core technology platform for integrated R&D and preclinical development of in...

August 23, 2023 | News

MGI Partners with NGeneBio to Advance Precision Medicine

This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceler...

August 23, 2023 | News

CanariaBio's MAb-AR20.5 for Pancreatic Cancer Granted FDA Orphan Drug Designation

CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immunotherapies for cancer, anno...

August 22, 2023 | News

Bruker to Acquire PhenomeX in All-Cash Deal

Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) announced that they have signed a definitive agreement for Bruker to acquire Pheno...

August 21, 2023 | News

Nagasaki University & NEC OncoImmunity Partner for Universal Vaccines Against Tropical Diseases

The collaboration between NOI and Nagasaki University aims to harness the power of advanced AI to optimize vaccine designs to be universally and broadly pr...

August 21, 2023 | News

Breakthrough 'eAir' Aero-Elastic Pressure Sensor from NUS Set to Revolutionize Medical Implants and Surgeries

The eAir sensor promises increased precision and reliability across medical applications. It can potentially transform laparoscopic surgeries by enabling t...

August 19, 2023 | News

Neurophth Begins Phase I/II Trial for Second Gene Therapy with First Patient Dosed

Neurophth is conducting a Phase I/II, multi-region, multi-center, single-arm, open-labeled, dose-finding study aimed at evaluating the safety, tole...

August 18, 2023 | News

Minghui Pharma Enrolls First Patient in Phase 3 Study for MH004 Cream in Atopic Dermatitis

The phase 3 clinical trial aims to evaluate the safety and efficacy of the investigational topical cream in a larger patient population. Leveraging the con...

August 18, 2023 | News

Stay Connected